Abbott nabs lab info systems maker Starlims
This article was originally published in The Gray Sheet
Diagnostics firm buys laboratory information management systems maker Starlims Technologies for $123 million in cash under a definitive agreement announced Dec. 14. The purchase, which includes web-based applications to help labs store, retrieve and analyze clinical and administrative data, "will provide Abbott with leading products to build upon existing technologies and expertise in the emerging field of health care informatics," Abbott said. The firm is paying $14 per share for Israel-based Starlims, a 47% premium over its Dec. 14 stock price close of $9.50
You may also be interested in...
ResMed plans to double or even triple production of intensive ventilators and sleep apnea machines this year amid rising demand by hospitals to use CPAP and BPAP machines to treat COVID-19 patients during the ventilator shortage.
Organizations like BARDA, CEPI and others are looking to partner with industry to rapidly test, manufacture, package and deploy vaccines and therapeutics, identifying areas they want to work together during BIO’s recent summit.
The economic stress on payers caused by the pandemic will cause a setback in the development of payment approaches for regenerative therapy, Blue Cross Blue Shield executive warns.